Kang-Ling Wang

5.8k total citations
47 papers, 2.6k citations indexed

About

Kang-Ling Wang is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kang-Ling Wang has authored 47 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 12 papers in Epidemiology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kang-Ling Wang's work include Atrial Fibrillation Management and Outcomes (19 papers), Cardiac Arrhythmias and Treatments (10 papers) and Blood Pressure and Hypertension Studies (9 papers). Kang-Ling Wang is often cited by papers focused on Atrial Fibrillation Management and Outcomes (19 papers), Cardiac Arrhythmias and Treatments (10 papers) and Blood Pressure and Hypertension Studies (9 papers). Kang-Ling Wang collaborates with scholars based in Taiwan, United States and United Kingdom. Kang-Ling Wang's co-authors include Tzeng‐Ji Chen, Chia‐Jen Liu, Yenn‐Jiang Lin, Yu‐Feng Hu, Ta‐Chuan Tuan, Shih‐Lin Chang, Su-Jung Chen, Pesus Chou, Hao‐Min Cheng and Shao‐Yuan Chuang and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Kang-Ling Wang

46 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kang-Ling Wang Taiwan 28 2.0k 420 365 289 252 47 2.6k
Faye L. Lopez United States 25 1.9k 0.9× 265 0.6× 221 0.6× 168 0.6× 149 0.6× 46 2.6k
Faye L. Norby United States 32 2.1k 1.0× 373 0.9× 252 0.7× 360 1.2× 183 0.7× 154 2.9k
Domenico Scrutinio Italy 22 1.2k 0.6× 223 0.5× 331 0.9× 163 0.6× 195 0.8× 105 1.9k
Saverio Iacopino Italy 24 3.1k 1.5× 235 0.6× 394 1.1× 128 0.4× 182 0.7× 158 3.6k
Carlo Rostagno Italy 24 1.4k 0.7× 392 0.9× 632 1.7× 139 0.5× 251 1.0× 130 2.2k
Wengen Zhu China 25 1.4k 0.7× 336 0.8× 227 0.6× 297 1.0× 107 0.4× 131 2.4k
Tze‐Fan Chao Taiwan 29 1.9k 1.0× 332 0.8× 165 0.5× 291 1.0× 175 0.7× 75 2.3k
Paul Chang United States 25 3.2k 1.6× 239 0.6× 211 0.6× 592 2.0× 358 1.4× 36 3.7k
Shinya Suzuki Japan 24 1.5k 0.7× 239 0.6× 315 0.9× 190 0.7× 147 0.6× 167 2.2k
Shih‐Hsien Sung Taiwan 28 2.1k 1.0× 359 0.9× 784 2.1× 96 0.3× 435 1.7× 155 3.1k

Countries citing papers authored by Kang-Ling Wang

Since Specialization
Citations

This map shows the geographic impact of Kang-Ling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang-Ling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang-Ling Wang more than expected).

Fields of papers citing papers by Kang-Ling Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kang-Ling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang-Ling Wang. The network helps show where Kang-Ling Wang may publish in the future.

Co-authorship network of co-authors of Kang-Ling Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Kang-Ling Wang. A scholar is included among the top collaborators of Kang-Ling Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kang-Ling Wang. Kang-Ling Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Citterio, Lorena, Giuseppe Bianchi, Giuseppe Scioli, et al.. (2021). Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan. The Pharmacogenomics Journal. 21(3). 346–358. 15 indexed citations
2.
3.
Li, Cheng-Hung, Chia‐Jen Liu, Annie Chou, et al.. (2016). European Society of Cardiology Guideline-Adherent Antithrombotic Treatment and Risk of Mortality in Asian Patients with Atrial Fibrillation. Scientific Reports. 6(1). 30734–30734. 10 indexed citations
4.
Chang, Yao-Ting, Yu‐Feng Hu, Jo‐Nan Liao, et al.. (2016). The assessment of anticoagulant activity to predict bleeding outcome in atrial fibrillation patients receiving dabigatran etexilate. Blood Coagulation & Fibrinolysis. 27(4). 389–395. 11 indexed citations
5.
Chao, Tze‐Fan, Chia‐Jen Liu, Jo‐Nan Liao, et al.. (2016). Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage. Circulation. 133(16). 1540–1547. 86 indexed citations
6.
Lu, Tse-Min, Pai‐Feng Hsu, Shih‐Hsien Sung, et al.. (2016). Long-term results of stenting versus coronary artery bypass surgery for left main coronary artery disease—A single-center experience. Journal of the Chinese Medical Association. 79(7). 356–362. 6 indexed citations
7.
Chao, Tze‐Fan, Chia‐Jen Liu, Kang-Ling Wang, et al.. (2015). Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?. Journal of the American College of Cardiology. 65(7). 635–642. 187 indexed citations
8.
Liao, Jo‐Nan, Tze‐Fan Chao, Chia‐Jen Liu, et al.. (2015). Risk and prediction of dementia in patients with atrial fibrillation — A nationwide population-based cohort study. International Journal of Cardiology. 199. 25–30. 79 indexed citations
9.
Chao, Tze‐Fan, Chia‐Jen Liu, Ta‐Chuan Tuan, et al.. (2015). Rate-Control Treatment and Mortality in Atrial Fibrillation. Circulation. 132(17). 1604–1612. 92 indexed citations
10.
Chao, Tze‐Fan, Chia‐Jen Liu, Su-Jung Chen, et al.. (2014). Does Digoxin Increase the Risk of Ischemic Stroke and Mortality in Atrial Fibrillation? A Nationwide Population-Based Cohort Study. Canadian Journal of Cardiology. 30(10). 1190–1195. 37 indexed citations
11.
Chao, Tze‐Fan, Chung‐Lieh Hung, Su-Jung Chen, et al.. (2013). The association between hyperuricemia, left atrial size and new-onset atrial fibrillation. International Journal of Cardiology. 168(4). 4027–4032. 75 indexed citations
12.
Hung, Chung‐Lieh, Tze‐Fan Chao, Yau‐Huei Lai, et al.. (2013). The Relationship Among Atrium Electromechanical Interval, Insulin Resistance, and Metabolic Syndrome. Canadian Journal of Cardiology. 29(10). 1263–1268. 12 indexed citations
13.
Chen, Su-Jung, Chia‐Jen Liu, Tze‐Fan Chao, et al.. (2013). Dental scaling and atrial fibrillation: A nationwide cohort study. International Journal of Cardiology. 168(3). 2300–2303. 35 indexed citations
14.
Wang, Kang-Ling, Chia‐Jen Liu, Tze‐Fan Chao, et al.. (2013). Risk of New-Onset Diabetes Mellitus Versus Reduction in Cardiovascular Events With Statin Therapy. The American Journal of Cardiology. 113(4). 631–636. 29 indexed citations
15.
Chao, Tze‐Fan, Chia‐Jen Liu, Su-Jung Chen, et al.. (2013). Hyperuricemia and the risk of ischemic stroke in patients with atrial fibrillation — Could it refine clinical risk stratification in AF?. International Journal of Cardiology. 170(3). 344–349. 42 indexed citations
16.
Chao, Tze‐Fan, Chia‐Jen Liu, Su-Jung Chen, et al.. (2012). CHADS2 score and risk of new-onset atrial fibrillation: A nationwide cohort study in Taiwan. International Journal of Cardiology. 168(2). 1360–1363. 46 indexed citations
17.
Chao, Tze‐Fan, Chia‐Jen Liu, Su-Jung Chen, et al.. (2012). The association between the use of non-steroidal anti-inflammatory drugs and atrial fibrillation: A nationwide case–control study. International Journal of Cardiology. 168(1). 312–316. 27 indexed citations
18.
Sung, Shih‐Hsien, Hao‐Min Cheng, Shao‐Yuan Chuang, et al.. (2012). Measurement of Central Systolic Blood Pressure by Pulse Volume Plethysmography With a Noninvasive Blood Pressure Monitor. American Journal of Hypertension. 25(5). 542–548. 17 indexed citations
19.
Huang, Chi-Ming, Yen‐Chung Lin, Yenn‐Jiang Lin, et al.. (2011). Risk stratification and clinical outcomes in patients with acute pulmonary embolism. Clinical Biochemistry. 44(13). 1110–1115. 24 indexed citations
20.
Cheng, Hao‐Min, Kang-Ling Wang, Ying-Hwa Chen, et al.. (2010). Estimation of central systolic blood pressure using an oscillometric blood pressure monitor. Hypertension Research. 33(6). 592–599. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Faye L. Lopez Breakdown of academic impact, for papers by Faye L. Norby Breakdown of academic impact, for papers by Domenico Scrutinio Breakdown of academic impact, for papers by Saverio Iacopino Breakdown of academic impact, for papers by Carlo Rostagno Breakdown of academic impact, for papers by Wengen Zhu Breakdown of academic impact, for papers by Tze‐Fan Chao Breakdown of academic impact, for papers by Paul Chang Breakdown of academic impact, for papers by Shinya Suzuki Breakdown of academic impact, for papers by Shih‐Hsien Sung
Rankless by CCL
2026